Shi X, Sheng Y, Fei H, Wei B, et al. Combined transcriptome and proteome analysis reveals MSN and ARFIP2 as biomarkers for trastuzumab resistance of breast cancer. Breast Cancer Res Treat 2024 May 15. doi: 10.1007/s10549-024-07355.
PMID: 38750271